Bortezomib and lenalidomide for multiple myeloma patients relapsed after allogeneic stem cell transplantation

被引：0
|
作者：
Corradini, P. [1 ]
Montefusco, V. [1 ]
Bruno, B. [2 ]
Merla, E. [3 ]
Sorasio, R. [2 ]
Olivieri, A. [4 ]
Falcone, A. [3 ]
Giaccone, L. [2 ]
Farina, L. [1 ]
Spina, F. [1 ]
Dodero, A. [1 ]
Milani, R. [1 ]
Carella, A. M. [3 ]
Cascavilla, N. [3 ]
机构：
[1] Ist Nazl Tumori, I-20133 Milan, IT, Italy
[2] Osped Giovanni Battista, Turin, IT, Italy
[3] Casa Sollievo Sofferenza Hosp, San Giovanni Rotondo, IT, Italy
[4] Osped San Carlo Borromeo Milano, Potenza, IT, Italy
来源：
BONE MARROW TRANSPLANTATION | 2009年 / 43卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S148 / S148
页数：1
相关论文
共 50 条
  • [31] Bortezomib for relapse after reduced-intensity conditioning allogeneic haematopoietic stem cell transplantation for multiple myeloma
    Michallet, M
    Duscatelle, S
    Rafii, H
    Troncy, J
    Thiebaut, A
    Thomas, X
    Tavernier, E
    Le, QH
    Raus, N
    Praire, A
    Nicolini, F
    BONE MARROW TRANSPLANTATION, 2005, 35 : S389 - S389
  • [32] Outcome after second stem cell transplantation for relapsed multiple myeloma
    Simpson, L.
    Verma, R.
    Kumar, S.
    Lacy, M.
    Dispenzieri, A.
    Hayman, S.
    Rajkumar, S. V.
    Litzow, M. R.
    Gertz, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [33] Outcome after second stem cell transplantation for relapsed multiple myeloma
    Simpson, L.
    Verma, R.
    Kumar, S.
    Lacy, M. Q.
    Dispenzieri, A.
    Hayman, S. R.
    Rajkumar, S. V.
    Litzow, M. R.
    Gertz, M. A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 188 - 189
  • [34] BORTEZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN THE MANAGEMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA
    Cerchione, C.
    Pareto, A. E.
    Zacheo, I.
    Di Perna, M.
    Nappi, D.
    Peluso, I.
    Ferrara, K.
    Pane, F.
    Catalano, L.
    HAEMATOLOGICA, 2018, 103 : S116 - S117
  • [35] Recovery of KIR expression after allogeneic stem cell transplantation in multiple myeloma patients
    Stuebig, T.
    Liznov, M.
    Fritsche-Friedland, U.
    Alchalby, H.
    Wolschke, C.
    Bacher, U.
    Zander, A.
    Kroeger, N.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S273 - S273
  • [36] Allogeneic stem cell transplantation for multiple myeloma
    Kroeger, N.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 29 - 29
  • [37] Outcomes of Maintenance Therapy with Bortezomib after Autologous Stem Cell Transplantation for Patients with Multiple Myeloma
    Sivaraj, Dharshan
    Green, Michael M.
    Li, Zhiguo
    Sung, Anthony D.
    Sarantopoulos, Stefanie
    Kang, Yubin
    Long, Gwynn D.
    Horwitz, Mitchell E.
    Lopez, Richard D.
    Sullivan, Keith M.
    Rizzieri, David A.
    Chao, Nelson J.
    Gasparetto, Cristina
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (02) : 262 - 268
  • [38] Maintenance therapy after allogeneic hematopoietic stem cell transplantation for patients with multiple myeloma
    Kawamura, Koji
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 118 (02) : 193 - 200
  • [39] Allogeneic stem cell transplantation for multiple myeloma
    Bensinger, WI
    Buckner, CD
    Gahrton, G
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1997, 11 (01) : 147 - &
  • [40] Maintenance therapy after allogeneic hematopoietic stem cell transplantation for patients with multiple myeloma
    Koji Kawamura
    International Journal of Hematology, 2023, 118 : 193 - 200
12345